Dengue Virus Diagnostic Tests Market 2028 By Test Type, End User and Geography | The Insight Partners

report image

Dengue Virus Diagnostic Tests Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Test Type (ELISA-based Tests, RT-PCR based Tests, Dengue IgG/IgM rapid Test, Others); End User (Hospitals, Clinics, Diagnostic Centers) and Geography

Report Code: TIPRE00006877 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

MARKET OVERVIEW

Dengue viruses are spread to humans via mosquito bites from infected Aedes species (Aedes aegypti or Aedes albopictus). Dengue fever is a viral that can be found in more than 100 countries around the world. The symptoms of dengue includes, body aches, high fever, muscle pain, nausea vomiting. ELISA or PCR-based blood tests are the most common method for diagnosing dengue virus. Rapid point-of-care tests, which have recently been developed, allow for early detection and notification of the disease. Dengue NS1 antigen testing and dengue IgM/IgG serological testing are the most often used tests.

MARKET SCOPE

The "Global Dengue Virus Diagnostic Tests Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the dengue virus diagnostic tests market with detailed market segmentation by test type and end user. The report provides key statistics on the market status of the leading dengue virus diagnostic tests market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on test type the market is segmented as, ELISA based tests, RT-PCR based tests, dengue IGG/IGM rapid test and others.
  •   Based on end user the market is segmented as, hospitals, clinics and diagnostic centers.

MARKET DYNAMICS
Drivers:

  •   High prevalence of dengue fever is the key driving factor for the market growth.
  •   Increasing awareness among people about effective dengue management and various government initiatives for early detections and treatment.
  •   Extensive R&D activities to develop more precise and accurate diagnostic tests for dengue.

Restraints:

  •   However, lack of awareness about the diagnostic tests in some developing and emerging nations is likley to restrain market growth during the forecast period.



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The dengue virus diagnostic tests market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the dengue virus diagnostic tests market in these regions.

IMPACT OF COVID-19 ON DENGUE VIRUS DIAGNOSTIC TESTS MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the dengue virus diagnostic tests market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from dengue virus diagnostic tests market are anticipated to lucrative growth opportunities in the future with the rising demand for dengue virus diagnostic tests in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the dengue virus diagnostic tests market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Abnova Corporation
  •   F. Hoffmann-La Roche Ltd
  •   Abbott
  •   InBios International, Inc
  •   Euroimmun AG
  •   Quest Diagnostics Incorporated
  •   CERTEST BIOTEC
  •   OriGene Technologies, Inc
  •   Thermo Fisher Scientific Inc.
  •   QuantuMDx Group Ltd
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

The List of Companies

- Abnova Corporation
- F. Hoffmann-La Roche Ltd
- Abbott
- InBios International, Inc
- Euroimmun AG
- Quest Diagnostics Incorporated
- CERTEST BIOTEC
- OriGene Technologies, Inc
- Thermo Fisher Scientific Inc.
- QuantuMDx Group Ltd
- BIOMÉRIEUX SA
- Apollo Diagnostics
TIPRE00006877
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




tip-analyst

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount